Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 187

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Cardiovascular and renal effects of growth hormone*

Caidahl, K., Edén, S., Bengtsson, B.‐Å. · 1994 · Clinical Endocrinology

Abstract

Summary: OBJECTIVE With the advent of recombinant human GH (rhGH), it has become possible in controlled clinical studies to explore the effects of GH replacement in adults with GH deficiency. The objective of this study was to determine cardiovascular and renal effects of GH replacement in adults with GH deficiency. PATIENTS We studied ten patients (one woman and nine men), mean age 47 years, with GH deficiency. DESIGN The patients were given s.c. rhGH (Humatrope, Ell Lilly) 0·5 U/kg/week or placebo in a 6‐month double blind cross‐over study. Cardiac and renal function was measured before drug administration (baseline), before cross‐over (i.e. after 6 months), and before termination of drug administration (after another 6 months). Analysis of variance was used to compare measurements during GH replacement with baseline and placebo measurements. One patient was excluded because of atrial fibrillation. MEASUREMENTS Main outcome measures were glomerular filtration rate and Doppler‐echocardiographic estimates of cardiac function and structure. Computerized exercise electrocardiogram, spirometry, and blood samples for analyses of plasma hormones were also obtained. RESULTS Left ventricular function was maintained during GH replacement. However, left ventricular mass increased from 211 to 249 g (P<0·05) mainly due to increased left ventricular dimension since wall thicknesses did not increase. The left atrium increased from 38 to 41 mm (P<0·05), possibly because stroke volume increased from 92 to 118 ml (P<0·0001) and cardiac output increased from 5·29 to 7·58 l/min (P<0·05). Total peripheral resistance decreased from 18·9 to 12·4 mmHg min/l (P<0·05), and diastolic blood pressure from 79 to 72 mmHg (P<0·05). Heart rate at rest increased from 58 to 70 beats/min. Systolic blood pressure at rest was unchanged, as was systolic blood pressure during dynamic exercise. GH replacement did not cause ST‐abnormalities. Serum creatinine decreased from 91·4 to 85·3 μmol/l (P<0·05) and glomerular filtration rate increased from 89·6 to 99·8 ml/min (P<0·01). CONCLUSIONS Thus, GH replacement has favourable cardiovascular and renal effects including increase of stroke volume and glomerular filtration rate with reduction of peripheral resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1994.tb03937.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 187

Metadata

Authors
Caidahl, K., Edén, S., & Bengtsson, B. ‐.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1994-03
Volume
40
Issue
3
Pages
393-400
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2086956756
Cited by
187
References
1
FWCI
5.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiovascular and renal effects of growth hormone*. https://app.cochat.ai/papers/10.1111/j.1365-2265.1994.tb03937.x
The paper
Caidahl, K., Edén, S., & Bengtsson, B. ‐. (1994). Cardiovascular and renal effects of growth hormone*. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1994.tb03937.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.